← Back to headlines
Moderna Gains as Arbutus/Genevant Settlement Removes Financial Risk
Moderna's stock gained after a settlement with Arbutus and Genevant removed a major financial risk for the company.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
